Directory of Approved Biopharmaceutical Products

by Spada; Stefania

• ISBN13: 9780415263689
• ISBN10: 0415263689
• Format: Hardcover
• Copyright: 2004-08-27
• Publisher: CRC Press

Summary

Biopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially available products. Until now, accessing data on the list of currently approved biopharmaceuticals has been laborious and patchy.Directory of Approved Biopharmaceutical Products brings together key information on various aspects of these compounds, presenting a brief summary of each biopharmaceutical currently approved for medical use. Each summary includes the scientific and trade name, year and regions approved, approved indications, manufacturer, marketing right, method of manufacture, scientific overview, and therapeutic properties. Based on information gathered from regulatory agencies and pharmaceutical manufacturers, the book presents the most comprehensive data currently available in a single, convenient volume.This comprehensive and consistent approach will save professionals in the pharmaceutical industry hours spent trawling the literature - and provides a singular resource for future reference.

Table of Contents

Actimmune	1	(3)
Activase	4	(2)
Aldurazyme	6	(3)
Ambirix	9	(2)
Amevive	11	(3)
Avonex	14	(3)
BeneFIX	17	(3)
Beromun	20	(3)
Betaferon/Betaseron	23	(3)
Bexxar	26	(3)
Bio-Tropin (Tev-Tropin or Zomacton)	29	(2)
Bioclate	31	(2)
CEA-Scan	33	(3)
Cerezyme	36	(3)
Comvax	39	(3)
Ecokinase (withdrawn from market)	42	(1)
Enbrel	43	(3)
Engerix-B	46	(2)
Epogen/Procrit	48	(3)
Fabrazyme	51	(3)
Fasturtec/Elitek	54	(3)
Forcaltonin	57	(3)
Forsteo/Forteo	60	(3)
Genotropin	63	(3)
GlucaGen	66	(2)
Glucagon	68	(2)
Gonal-F	70	(3)
HBVAXPRO	73	(2)
Helixate NexGen/Helixate FS/Kogenate FS	75	(3)
Hepacare (withdrawn from market)	78	(3)
Herceptin	81	(3)
Hexavac	84	(3)
Humalog	87	(3)
HumaSPECT	90	(3)
Humatrope	93	(3)
Humira	96	(3)
Humulin	99	(3)
Indimacis 125 (withdrawn from market)	102	(2)
InductOs	104	(3)
INFANRIX HepB	107	(3)
Infanrix Hexa	110	(3)
Infanrix Penta/Pediarix	113	(3)
Infergen	116	(2)
InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Device	118	(3)
Insuman	121	(3)
Intron A	124	(4)
Kineret	128	(2)
Lantus	130	(2)
Leukine	132	(3)
LeukoScan	135	(3)
Liprolog (withdrawn from market)	138	(1)
Luveris	139	(3)
LYMErix (withdrawn from market)	142	(2)
MabCampath/Campath-1H	144	(3)
MabThera/Rituxan	147	(3)
Metalyse/TNKase	150	(3)
Mylotarg	153	(3)
Myoscint (withdrawn from market)	156	(3)
Natrecor	159	(2)
NeoRecormon	161	(3)
Nespo/Aranesp	164	(3)
Neulasta	167	(3)
Neumega	170	(2)
Neupogen	172	(2)
Norditropin	174	(2)
Novolin/Actrapid/Insulatard/Mixtard/Monotard/Ultratard/Velosulin	176	(4)
NovoRapid/Novolog and NovoMix 30/NovoLog Mix 70/30	180	(3)
Novoseven	183	(3)
Nutropin Depot	186	(3)
NutropinAQ	189	(3)
OncoScint CR/OV	192	(3)
Ontak	195	(3)
Optisulin	198	(2)
Orthoclone OKT-3	200	(3)
Osigraft/OP-1 Implant	203	(2)
Ovitrelle/Ovidrel	205	(2)
Pegasys	207	(2)
PegIntron	209	(3)
Primavax (withdrawn from market)	212	(2)
Procomvax/Comvax	214	(3)
Proleukin	217	(3)
ProstaScint	220	(3)
Protropin	223	(2)
Pulmozyme	225	(3)
Puregon/Follistim	228	(3)
Rapilysin/Retavase	231	(3)
Rebetron	234	(2)
Rebif	236	(2)
Recombinate	238	(2)
Recombivax	240	(2)
ReFacto	242	(3)
Refludan	245	(3)
Regranex	248	(2)
Remicade	250	(3)
ReoPro	253	(3)
Replagal	256	(2)
Revasc	258	(2)
Roferon A	260	(3)
Saizen	263	(2)
Serostim	265	(3)
Simulect	268	(3)
Somavert	271	(3)
Synagis	274	(3)
Tecnemab K1 (withdrawn from market)	277	(2)
Thyrogen	279	(3)
Triacelluvax (withdrawn from market)	282	(2)
Tritanrix HepB	284	(2)
Twinrix Adult	286	(3)
Twinrix Paediatric	289	(2)
Verluma	291	(3)
Viraferon	294	(2)
ViraferonPeg	296	(2)
Vitravene (withdrawn from E.U. market)	298	(3)
Xigris	301	(3)
Xolair	304	(3)
Zenapax	307	(3)
Zevalin	310	(3)
Appendix	313